Articles

  1. Vaccine And Virus Manufacturing And Testing 4/14/2014

    Charles River Biologics Testing Solutions can help you expedite your vaccine development program by providing you with manufacturing for early-phase clinical trials through to lot release for commercial products.

  2. The Environmental Impact of Clinical Trials 8/8/2013

    For many years it has been almost universally accepted that there are various sources that may impact or cause disease among which biological, social, and environmental differences have all been investigated. Many clinical trials have been conducted to assess the impact of the environment on outcomes e.g., the effect of the environment on the outcome of studies assessing the efficacy of drugs for patients with dry-eye syndrome, the impact of diet on obesity and cardiovascular disease, and the impact of the environment on autoimmune diseases have all been studied, as have many other interactions.

  3. Adding Value To The Drug Development Process 4/30/2012

    Life science companies can gain advantages from working with external partners that can bridge the divide between drug development and commercialization. By William Crown, Ph.D.

  4. Track And Trace In China 2/9/2012
    Track and trace technology has significant value for both industry and society. Both Chinese industry and the government are increasing efforts to promote the establishment of a reliable, safe traceability system. By Yuxiang Zhang
  5. Brochure: Pharma Sterile Dosage Forms 1/30/2012

    DSM offers pharmaceutical and biopharmaceutical customers a lyophilization system with unique benefits. It has the precision to serve increasingly demanding lyophilization cycles, a critical requirement for successful product launches and high commercial yields. 

  6. Case Study: Flu Vaccine Trial Accelerated Despite Late-In-Season Start 5/11/2011
    Streamlined processes for study startup, coupled with experience in vaccine trials and solid relationships with study sites and investigators, helped this Quintiles team meet the challenge of starting an influenza vaccine trial late in the influenza season.
  7. Targeting Oncology 5/11/2011
    In the search to improve cancer outcomes, each promising advance across the biopharmaceutical frontier comes with challenges as unique as the specific molecular pathway and individual genetic profile it targets.
  8. White Paper: FDA Requirements For Clinical Studies In Pediatric Patients 5/11/2011

    FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy and safety in children.

  9. Advancing Vaccine Development 5/11/2011
    With extensive experience in vaccines development, as well as market access and commercialization strategy, Quintiles is uniquely qualified to be your ally in vaccines.
  10. Article: The 'Rogue' Biologist Speaks His Mind 3/6/2011
    Synthetic biology is one of the hottest and most rapidly growing new fields in life sciences. By Cliff Mintz Ph.D., Life Science Leader magazine